October 28, 2014 - Share Price $6.00 “Noted Karol Gray, CFO of Applied DNA Sciences: ‘The reverse split has had very solid support from shareholders, and from the Board. We believe the changes in capital structure can strongly benefit our shareholders.'"
5 years later
October 31, 2019 - Share Price 17.25 cents
“The reverse split has had very solid support from stockholders, and from the board of directors. We believe the change in capital structure can strongly benefit our stockholders,” stated Dr. James A. Hayward, Chairman, President and CEO of Applied DNA.